Uluru Co., Ltd.
Uluru Co., Ltd. (3979) is a Japanese company primarily engaged in the development and commercialization of innovative pharmaceutical products, particularly focusing on regenerative medicine and drug delivery systems. The company operates within the biotechnology sector, leveraging advanced technologies to create therapies that address unmet medical needs. Its core offerings include proprietary products designed for the treatment of various diseases, alongside a range of research and development services aimed at enhancing the efficacy and safety of pharmaceuticals.